Test79: Unterschied zwischen den Versionen

Aus Hl7wiki
Wechseln zu: Navigation, Suche
 
(2 dazwischenliegende Versionen desselben Benutzers werden nicht angezeigt)
Zeile 1: Zeile 1:
−
{{HL7transclude| cdaab3:Anrede-Section (Template)}}
+
{|class="hl7table"
−
{{HL7transclude| cdaab3:Grund_der_Überweisung-Section_(Template)}}
+
!codeSystem!!codeSystemName and Description!!Owner
−
{{HL7transclude| cdaab3:Anamnese-Section (Template)}}
+
|- valign=top
−
{{HL7transclude| cdaab3:Impfung-Section (Template)}}
+
|2.16.840.1.113883.6.1
−
{{HL7transclude| cdaab3:Befund-Section (Template)}}
+
|LOINC<br/>''Logical Observation Identifier Names and Codes''
−
{{HL7transclude| cdaab3:Diagnose-Section (Template)}}
+
|Regenstrief Institute
−
{{HL7transclude| cdaab3:besondere Hinweise-Section (Template)}}
 
  
−
{{HL7transclude| cdaab3:Allergien-Section (Template)}}
+
|- valign=top
−
{{HL7transclude| cdaab3:Gesundheitsprobleme_(Template)}}
+
|2.16.840.1.113883.6.8
−
{{HL7transclude| cdaab3:Risiken-Section (Template)}}
+
|UCUM<br/>''Unified Code for Units of Measure''
 +
|Regenstrief Institute, and the UCUM Organization
  
−
{{HL7transclude| cdaab3:Medikation-Section (Template)}}
+
|- valign=top
 +
|2.16.840.1.113883.6.96
 +
|SNOMED-CT<br/>''Systematized Nomenclature of Medicine – Clinical Terms''
 +
|IHTSDO/Snomed International
  
−
{{HL7transclude| cdaab3:Medikation bei Aufnahme-Section (Template)}}
+
|- valign=top
−
{{HL7transclude| cdaab3:Medikation bei Entlassung-Section (Template)}}
+
|1.3.6.1.4.1.19376.1.5.3.2
−
{{HL7transclude| cdaab3:jetzige Medikation-Section (Template)}}
+
|IHEActCode<br/>''Vocabulary defined by IHE PCC in PCC TF-2:5.1.2, used for representing annotation comments in the report''
 +
|IHE PCC
  
−
{{HL7transclude| cdaab3:Massnahme-Section (Template)}}
+
|- valign=top
−
{{HL7transclude| cdaab3:Heil-_und_Hilfsmittel_(Template)}}
+
|2.16.840.1.113883.5.4
 +
|Act Code<br/>''Codesystem for Acts''
 +
|HL7 International
  
−
{{HL7transclude| cdaab3:Notiz-Section (Template)}}
+
|- valign=top
 +
|2.16.840.1.113883.5.6
 +
|ActClass<br/>''Codesystem for Act Classes''
 +
|HL7 International
  
−
{{HL7transclude| cdaab3:Epikrise-Section (Template)}}
+
|- valign=top
 +
|2.16.840.1.113883.5.1052
 +
|Act Site<br/>''Codesystem for Act Sites''
 +
|HL7 International
  
−
{{HL7transclude| cdaab3:Labordaten-Section (Template)}}
+
|- valign=top
 +
|2.16.840.1.113883.5.1065
 +
|ProcedureMethod<br/>''Codesystem for Procedure Methods''
 +
|HL7 International
  
−
{{HL7transclude| cdaab3:Empfohlene_Maßnahmen (Template)}}
+
|- valign=top
−
{{HL7transclude| cdaab3:Schlusstext-Section (Template)}}
+
|2.16.840.1.113883.5.111
−
{{HL7transclude| cdaab3:Anhang-Section (Template)}}
+
|Role Code<br/>''Codesystem for Role Codes''
 +
|HL7 International
  
 +
|- valign=top
 +
|2.16.840.1.113883.5.129
 +
|SpecimenType<br/>''Codesystem for Specimen Types''
 +
|HL7
  
 +
|- valign=top
 +
|2.16.840.1.113883.5.83
 +
|ObservationInterpretation<br/>''One or more codes specifying a rough qualitative interpretation of the observation, such as "normal", "abnormal", "below normal", "change up", "resistant", "susceptible", etc.''
 +
|HL7 International
  
 +
|- valign=top
 +
|2.16.840.1.113883.5.84
 +
|ObservationMethod<br/>''A code system that provides additional detail about the means or technique used to ascertain the observation''
 +
|HL7 International
  
 +
|- valign=top
 +
|2.16.840.1.113883.6.3
 +
|ICD-10<br/>''International Classification of Diseases revision 10''
 +
|WHO
  
−
{{HL7transclude| cdaab3:Empfänger (informationRecipient) (Template)}}
+
|- valign=top
−
{{HL7transclude| cdaab3:Unterzeichner gesetzlich verantwortlich (legalAuthenticator) (Template)}}
+
|2.16.840.1.113883.6.43
−
{{HL7transclude| cdaab3:Unterzeichner (Authenticator) (Template)}}
+
|ICD-O-3<br/>''International Classification of Diseases for Oncology revision 3''
−
{{HL7transclude| cdaab3:Datentypist (dataEnterer) (Template)}}
+
|WHO
−
{{HL7transclude| cdaab3:Informant (informant) (Template)}}
+
 
−
{{HL7transclude| cdaab3:Einweisender_Arzt (participant) (Template)}}
+
|- valign=top
−
{{HL7transclude| cdaab3:Hausarzt (participant) (Template)}}
+
| 1.2.840.10008.2.16.4
−
{{HL7transclude| cdaab3:Notfallkontakt (participant) (Template)}}
+
|DICOM controlled vocabulary<br/>''The meanings of codes defined in DICOM, either explicitly or by reference to another part of DICOM or an external reference document or standard <ref> DICOM controlled vocabulary http://nema.org/dicom/dicm]</ref>''
−
{{HL7transclude| cdaab3:Angehörige (participant) (Template)}}
+
|DICOM
−
{{HL7transclude| cdaab3:Versicherter/Versicherung (participant) (Template)}}
+
 
−
{{HL7transclude| cdaab3:Betreuungsorganisation (participant) (Template)}}
+
|- valign=top
−
{{HL7transclude| cdaab3:Weitere Beteiligte (participant) (Template)}}
+
|2.16.840.1.113883.15.6
−
{{HL7transclude| cdaab3:Patientenkontakt (EncompassingEncounter) (Template)}}
+
|TNM 7th edition<br/>''Internationally agreed-upon standards to describe and categorize cancer stages and progression <ref name="uicctnm">UICC TNM http://www.uicc.org/resources/tnm</ref>''
 +
|Union for International Cancer Control (UICC) & American Joint Committee on Cancer (AJCC)
 +
 
 +
|- valign=top
 +
|2.16.840.1.113883.15.7
 +
|TNM 6th edition<br/>''Internationally agreed-upon standards to describe and categorize cancer stages and progression <ref name="uicctnm"/>''
 +
|Union for International Cancer Control (UICC) & American Joint Committee on Cancer (AJCC)
 +
 
 +
|- valign=top
 +
|2.16.840.1.113883.15.8
 +
|TNM 5th edition<br/>''Internationally agreed-upon standards to describe and categorize cancer stages and progression <ref name="uicctnm"/>''
 +
|Union for International Cancer Control (UICC) & American Joint Committee on Cancer (AJCC)
 +
 
 +
|- valign=top
 +
|2.16.840.1.113883.6.4
 +
|ICD-10-PCS<br/>''International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS)''
 +
|WHO
 +
 
 +
|- valign=top
 +
|1.2.276.0.76.5.464
 +
|OPS 2017<br/>''Code lists to describe and categorize surgeries and procedures, adapted from WHO ICPM for Germany''
 +
|DIMDI / (WHO)
 +
 
 +
|- valign=top
 +
|2.16.840.1.113883.6.174
 +
|OMIM<br/>''Code lists to describe and categorize human genes. OMIM is a comprehensive, authoritative compendium of human genes and genetic phenotypes that is freely available and updated daily.''
 +
|OMIM Johns Hopkins University School of Medicine [http://www.omim.org]
 +
 
 +
|- valign=top
 +
|1.2.276.0.76.3.1.131.1.5.1
 +
|DKG Coding Scheme<br/>''Internationally agreed-upon code lists to describe and categorize cancer grading systems, adapted for Germany <ref>CDA Assessment Scales Entry DKG-Labels http://wiki.hl7.de/index.php?title=cdaonk:Assessment_Scales_Entry_(Template)#aus_DKG-Labels_.28OID.3D1.2.276.0.76.3.1.131.1.5.1.29</ref>''
 +
|DKG (Deutsche Krebsgesellschaft)
 +
 
 +
|- valign=top
 +
|1.2.276.0.76.5.336
 +
|Grading / Differentiation scheme<br/>''Code lists to describe and categorize Tumor grading according ICD-O-3, adapted for Germany''
 +
||HL7 Germany
 +
 
 +
|- valign=top
 +
|1.2.276.0.76.5.401
 +
|Localization scheme for distant metastases<br/>''Code lists to describe and categorize localization of metastases according UICC, adapted for Germany''
 +
|HL7 Germany
 +
|}

Aktuelle Version vom 9. Juli 2017, 11:44 Uhr

codeSystem codeSystemName and Description Owner
2.16.840.1.113883.6.1 LOINC
Logical Observation Identifier Names and Codes 		Regenstrief Institute
2.16.840.1.113883.6.8 UCUM
Unified Code for Units of Measure 		Regenstrief Institute, and the UCUM Organization
2.16.840.1.113883.6.96 SNOMED-CT
Systematized Nomenclature of Medicine – Clinical Terms 		IHTSDO/Snomed International
1.3.6.1.4.1.19376.1.5.3.2 IHEActCode
Vocabulary defined by IHE PCC in PCC TF-2:5.1.2, used for representing annotation comments in the report 		IHE PCC
2.16.840.1.113883.5.4 Act Code
Codesystem for Acts 		HL7 International
2.16.840.1.113883.5.6 ActClass
Codesystem for Act Classes 		HL7 International
2.16.840.1.113883.5.1052 Act Site
Codesystem for Act Sites 		HL7 International
2.16.840.1.113883.5.1065 ProcedureMethod
Codesystem for Procedure Methods 		HL7 International
2.16.840.1.113883.5.111 Role Code
Codesystem for Role Codes 		HL7 International
2.16.840.1.113883.5.129 SpecimenType
Codesystem for Specimen Types 		HL7
2.16.840.1.113883.5.83 ObservationInterpretation
One or more codes specifying a rough qualitative interpretation of the observation, such as "normal", "abnormal", "below normal", "change up", "resistant", "susceptible", etc. 		HL7 International
2.16.840.1.113883.5.84 ObservationMethod
A code system that provides additional detail about the means or technique used to ascertain the observation 		HL7 International
2.16.840.1.113883.6.3 ICD-10
International Classification of Diseases revision 10 		WHO
2.16.840.1.113883.6.43 ICD-O-3
International Classification of Diseases for Oncology revision 3 		WHO
1.2.840.10008.2.16.4 DICOM controlled vocabulary
The meanings of codes defined in DICOM, either explicitly or by reference to another part of DICOM or an external reference document or standard [1] 		DICOM
2.16.840.1.113883.15.6 TNM 7th edition
Internationally agreed-upon standards to describe and categorize cancer stages and progression [2] 		Union for International Cancer Control (UICC) & American Joint Committee on Cancer (AJCC)
2.16.840.1.113883.15.7 TNM 6th edition
Internationally agreed-upon standards to describe and categorize cancer stages and progression [2] 		Union for International Cancer Control (UICC) & American Joint Committee on Cancer (AJCC)
2.16.840.1.113883.15.8 TNM 5th edition
Internationally agreed-upon standards to describe and categorize cancer stages and progression [2] 		Union for International Cancer Control (UICC) & American Joint Committee on Cancer (AJCC)
2.16.840.1.113883.6.4 ICD-10-PCS
International Classification of Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) 		WHO
1.2.276.0.76.5.464 OPS 2017
Code lists to describe and categorize surgeries and procedures, adapted from WHO ICPM for Germany 		DIMDI / (WHO)
2.16.840.1.113883.6.174 OMIM
Code lists to describe and categorize human genes. OMIM is a comprehensive, authoritative compendium of human genes and genetic phenotypes that is freely available and updated daily. 		OMIM Johns Hopkins University School of Medicine [1]
1.2.276.0.76.3.1.131.1.5.1 DKG Coding Scheme
Internationally agreed-upon code lists to describe and categorize cancer grading systems, adapted for Germany [3] 		DKG (Deutsche Krebsgesellschaft)
1.2.276.0.76.5.336 Grading / Differentiation scheme
Code lists to describe and categorize Tumor grading according ICD-O-3, adapted for Germany 		HL7 Germany
1.2.276.0.76.5.401 Localization scheme for distant metastases
Code lists to describe and categorize localization of metastases according UICC, adapted for Germany 		HL7 Germany
  1. ↑ DICOM controlled vocabulary http://nema.org/dicom/dicm]
  2. ↑ 2,0 2,1 2,2 UICC TNM http://www.uicc.org/resources/tnm
  3. ↑ CDA Assessment Scales Entry DKG-Labels http://wiki.hl7.de/index.php?title=cdaonk:Assessment_Scales_Entry_(Template)#aus_DKG-Labels_.28OID.3D1.2.276.0.76.3.1.131.1.5.1.29
Abgerufen von „https://wiki.hl7.de/index.php?title=Test79&oldid=40045“